ClinicalTrials.gg
CompletedNCT02001298Updated Dec 4, 2013

Remifentanil and Nitroprusside for Controlled Hypotension

An interventional study of remifentanil and nitroprusside in Hypotension, Controlled, sponsored by Jeju National University School of Medicine. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2013-12-04.

Sponsored by Jeju National University School of Medicine · Not applicable and Interventional

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Hypotension with a site in Korea, Republic of — 4 open to participants now, 4 under way, none of them phase 3. Hypotension · Korea, Republic of.

Enrollment
25th of 27
30 · median 87
Started
2012
with 2 others
No phase
23 of 38
3 open now
Registered
7th of 38
by date

Among the 38 studies in Hypotension with a site in Korea, Republic of, this one is the 25th largest by enrollment of the 27 interventional ones that give a count, is one of 3 that started in 2012, is one of 23 with no phase, and was the 7th registered.

Hypotension

892 studies on the registry are indexed under Hypotension; 199 are open to participants now.

Browse Hypotension studies →

Open to participants now

4 of the 38 studies in Hypotension with a site in Korea, Republic of are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 114 Hypotension studies recruiting now, 53 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.

This study: 20 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Hypotension with a site in Korea, Republic of, or all of them as a file.
02

Study summary

The purpose of this study is the comparison of the cardiovascular effects of remifentanil and nitroprusside for controlled hypotension

03

Conditions studied

  • Hypotension, Controlled

Browse trials for

Keywords

  • remifentanil
  • nitroprusside
  • hypotension
04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who underwent endoscopic sinus surgery

Exclusion criteria

Exclusion Criteria:

  • patient who took any drug to influence this study
  • patient with cardiovascular disease, renal disease or liver disease
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    nitroprusside

    After induction of anesthesia, controlled hypotension was induced with continuous infusion of nitroprusside. Cardiac index, stroke volume index, and total peripheral resistance index were continuously measured using noninvasive cardiac output monitor (Cheetah NICOM, Cheetah Medical Inc, UK).

    Drug: nitroprusside

  • Experimental
    remifentanil

    After induction of anesthesia, controlled hypotension was induced with continuous infusion of remifentanil. Cardiac index, stroke volume index, and total peripheral resistance index were continuously measured using noninvasive cardiac output monitor (Cheetah NICOM, Cheetah Medical Inc, UK).

    Drug: remifentanil

Interventions

06

What researchers measure

Primary outcomes

  1. Cardiac index

    Cardiac index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of cardiac index during controlled hypotension was compared with baseline value.

    Time frame: Cardiac index was continuously measured during controlled hypotension, an average of 90 min

Secondary outcomes

  1. Total peripheral resistance index

    Total peripheral resistance index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of total peripheral resistance index during controlled hypotension was compared with baseline value.

    Time frame: Total peripheral resistance index was continuously measured during controlled hypotension, an average of 90 min

Other outcomes

  1. Stroke volume index

    Stroke volume index was continuously measured during controlled hypotension using noninvasive cardiac output monitor. The average of stroke volume index during controlled hypotension was compared with baseline value.

    Time frame: Stroke volume index was continuously measured during controlled hypotension, an average of 90 min

07

Study locations

1 site
  • Jeju National University Hospital
    Jeju-si, Jeju Special Self-Governing Province 690-767, Korea, Republic of
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2012 and a primary completion of Jul 2013. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 24, 2013
First posted
Dec 4, 2013
Start
Jun 2012
Primary completionActual
Jul 2013
Last update
Dec 4, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02001298
Lead sponsor
Jeju National University School of Medicine
Responsible party
Hyun Jung Kim (Assistant professor, Jeju National University School of Medicine) — Principal investigator
First posted
Dec 4, 2013
Start date
Jun 2012
Primary completion
Jul 2013
Last update
Dec 4, 2013
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Remifentanil · Nitroprusside

Start the discussion